{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:37:56Z","timestamp":1792467476725,"version":"4.5.0"},"reference-count":22,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T00:00:00Z","timestamp":1276560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p><jats:bold>Aim\u2002<\/jats:bold> Botulinum neurotoxin type A (BoNT\u2010A) has been described as an effective intervention for drooling and is being increasingly adopted. However, its effectiveness compared with established treatments is still unknown. We undertook a within\u2010participants observational study to examine this.<\/jats:p><jats:p><jats:bold>Method\u2002<\/jats:bold> An historic cohort was formed of 19 children and young adults (10 males, nine females) with severe drooling who underwent BoNT\u2010A injections followed by surgical re\u2010routing of the submandibular duct at least 6\u2003months later. Mean age at time of admission was 11\u2003years 5\u2003months (range 5\u201317y) and mean age at the time of surgery was 14\u2003years (range 6\u201323y). Fifteen children were diagnosed with bilateral cerebral palsy (CP), three with unilateral CP, and one with non\u2010progressive developmental delay. Gross Motor Function Classification System levels were the following: level I, <jats:italic>n<\/jats:italic>=1; level II, <jats:italic>n<\/jats:italic>=2; level III, <jats:italic>n<\/jats:italic>=7; level IV, <jats:italic>n<\/jats:italic>=6; and level V, <jats:italic>n<\/jats:italic>=3). The primary outcome was the drooling quotient, which was assessed before each intervention and 8 and 32\u2003weeks thereafter. A multivariate analysis of variance of repeated measures was performed, with the measurement points as the within\u2010participant variables.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The drooling quotient was reduced to a greater extent after surgery than after BoNT\u2010A administration (<jats:italic>p<\/jats:italic>=0.001). Compared with a baseline value of 28, the mean drooling quotient 8\u2003weeks after surgery was 10, and 32\u2003weeks after surgery was 4 (<jats:italic>p<\/jats:italic>&lt;0.001). Among the group treated with BoNT\u2010A, the drooling quotient showed a significant reduction from a baseline value of 30 to 18 after 8\u2003weeks (<jats:italic>p<\/jats:italic>=0.02), and a continued but diminished effect after 32\u2003weeks (drooling quotient 22; <jats:italic>p<\/jats:italic>=0.05).<\/jats:p><jats:p><jats:bold>Interpretation\u2002<\/jats:bold> Both interventions are effective, but surgery provides a larger and longer\u2010lasting effect.<\/jats:p>","DOI":"10.1111\/j.1469-8749.2010.03713.x","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T10:26:12Z","timestamp":1276597572000},"page":"1038-1042","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Botulinum toxin versus submandibular duct relocation for severe drooling"],"prefix":"10.1111","volume":"52","author":[{"given":"ARTHUR RT","family":"SCHEFFER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CORRIE","family":"ERASMUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAREN","family":"VAN HULST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JACQUES","family":"VAN LIMBEEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN J","family":"ROTTEVEEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER H","family":"JONGERIUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANK JA","family":"VAN DEN HOOGEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"691","article-title":"Drooling in children with cerebral palsy","volume":"34","author":"Van De Heyning PH","year":"1980","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-263X.1998.00055.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.43.3.155"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2005.07.021"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215106004105"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000182221.11733.12"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.2007.01388.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2001.tb00225.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100115051"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310100784"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142040.57474.A6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-1104-L"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2006.01939a.x"},{"key":"e_1_2_6_15_2","first-page":"16","article-title":"Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy","volume":"703","author":"Lin YC","year":"2008","journal-title":"Neurology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.02015.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.084681"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200301000-00020"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1980.tb04349.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2007.00504.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200201000-00014"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.00390.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/0145445506298723"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2010.03713.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.2010.03713.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:51:32Z","timestamp":1698781892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.2010.03713.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1469-8749.2010.03713.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03713.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]},"assertion":[{"value":"2010-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}